How much is Babylon Biosciences worth in 2026?

Babylon Biosciences has a current valuation of N/A based on their Seed Round round and secondary market data.

How much funding has Babylon Biosciences raised?

Babylon Biosciences has raised N/A in total funding across 1 funding rounds.

Babylon Biosciences

Drug Discovery

Babylon Biosciences valuation and funding history | Last updated: July 1, 2024 | 1 funding rounds

Current Valuation

N/A

As of July 1, 2024

Total Funding Raised

N/A

Across 1 round

Last Round

Seed Round

Amount undisclosed

Last Funding

Jul 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
July 1, 2024	Seed Round	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

Babylon Biosciences is currently valued at N/A as of July 1, 2024.

Track Babylon Biosciences Valuation Updates

Get notified when Babylon Biosciences raises new funding or valuation changes

Explore More Data

Detailed analysis for Babylon Biosciences

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Babylon Biosciences's valuation history, funding rounds, and growth metrics.

No credit card required

What is Babylon Biosciences Worth in 2026?

Babylon Biosciences is a leading private company in the Drug Discovery sector. Track Babylon Biosciences's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Babylon Biosciences Valuation is Determined

Private company valuations like Babylon Biosciences's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.